Clinical AI tools are expanding across specialties, prompting renewed focus on how to measure their quality and efficacy. Industry leaders, clinicians, and regulators argue that benchmarks must go beyond accuracy to capture real-world impact, safety, and equity. The article notes that prospective validation, diverse representative datasets, and rigorous external testing are essential to avoid overfitting to narrow populations and settings.
Experts advocate a framework combining technical metrics (calibration, discrimination, robustness) with clinical outcomes and workflow impact (decision support, time saved, diagnostic confidence). They stress ongoing monitoring, post-deployment surveillance, and transparent reporting, including biases and limitations. Challenges include data quality, access to real-world data, and interoperability. The piece urges standardized standards, shared benchmarks, and governance to ensure AI tools improve care without compromising safety or fairness.
